HNGE logo

Hinge Health Inc

HNGE

Build a strategy around HNGE

Accountable AI Logo

Hinge Health Inc AI Insights

Informational only. Not investment advice.
As of 2025-12-12

Snapshot

  • Revenue grew 53% YoY (534M TTM) vs industry median 7% - 7x faster growth rate signals category leadership[Total Revenue 1Y Growth]
  • FCF of 141M TTM (26% margin) despite -533M net loss - cash generation decoupled from GAAP losses[Free Cash Flow]
  • R&D at 357M TTM (67% of revenue) vs 973M total opex - growth investment phase, not structural burn[Research and Development]

Watch Triggers

  • Operating Margin: Improves to better than -50%Would signal R&D leverage kicking in and path to GAAP profitability accelerating
  • Total Revenue 1Y Growth: Decelerates below 30%Growth deceleration without margin improvement would invalidate scale thesis
  • Free Cash Flow: Turns negativeFCF is key proof point - negative FCF would signal model deterioration

Bull Case

79% gross margin (vs 54% median) + 53% revenue growth = SaaS-like unit economics in healthcare. FCF positive at 141M proves model works at scale.

Gross MarginTotal Revenue 1Y GrowthFree Cash Flow

Minimal debt (9M, 0.04 D/E) with 261M cash provides 2+ years runway without dilution even at current burn rate.

Total DebtDebt to EquityCash and Equivalents

Bear Case

P/S of 7.3x vs 1.7x median (4.4x premium) prices in perfection. -553M operating loss means years of execution risk ahead.

PS RatioOperating Income

Operating margin -103% TTM with 973M opex on 534M revenue - must nearly double revenue just to break even on operations.

Operating MarginOperating ExpenseTotal Revenue

Bull vs Bear Balance

AI-generated sentiment analysis based on fundamental metrics and market conditions.

BearBull
45%

Leverage HNGE's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.

Take Me to The Editor

Forward Thesis

Path to profitability within 18 months as R&D leverage improves with scale

1-3ymed
  • 79% gross margin provides operating leverage runway
  • R&D as % of revenue should decline with scale
  • FCF already positive at 26% margin
Gross margin 79% TTM vs 54% industry medianFCF 141M positive despite -553M operating lossRevenue 53% growth provides scaling base

Valuation Context

Caveats

Data Partners
Morningstar Logo

Fundamental company data provided by Morningstar, updated daily.

Accountable Finance, Inc. Disclaimer
accountable.finance is not operated by a broker or a dealer. Under no circumstances does any information posted on accountable.finance represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. In no event shall accountable.finance be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on accountable.finance, or relating to the use of, or inability to use, accountable.finance or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Stock quotes and fundamental company data provided by Morningstar, updated daily.

Accountable Logo
© 2026 Accountable Finance, Inc. All rights reserved.